Innovators in Blood and Marrow Stem Cell Transplantation
The Duke Division of Cellular Therapy is internationally recognized for its novel approaches to treating leukemia, lymphoma, and myeloma through bone marrow and stem cell transplantation. We also treat novel indications such as autoimmune disease and hemoglobinopathies. Learn more about Duke Cellular Therapy.
PrintAddThis
Share
E-mailNews and Events
Read the latest news and events from Duke Cellular Therapy:
Duke Awarded up to $43 Million to Develop Test for Dirty Bomb Radiation Exposure
Patient Care
Every year, patients from all over the country and other nations receive bone marrow or stem cell transplantation at Duke. Learn more about our patient care services at DukeHealth.org.
